Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-05

Clinical Trial Update: Use of Chamomilla Recutita in Phlebitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Chamomilla recutita (chamomile) for phlebitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chamomilla recutita (Chamomilla recutita (Matricaria recutita))

Snippet

Sponsor: University of Sao Paulo | Conditions: Phlebitis | Phase 3 | Status: COMPLETED